BRAVYL Trademark

Trademark Overview

On Tuesday, February 16, 2021, a trademark application was filed for BRAVYL with the United States Patent and Trademark Office. The USPTO has given the BRAVYL trademark a serial number of 90530755. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by Woolsey Pharmaceuticals, Inx.. The BRAVYL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system
bravyl

General Information

Serial Number90530755
Word MarkBRAVYL
Filing DateTuesday, February 16, 2021
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6981276
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesPharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 18, 2021
Primary Code005
First Use Anywhere DateMonday, December 12, 2022
First Use In Commerce DateMonday, December 12, 2022

Trademark Owner History

Party NameWoolsey Pharmaceuticals, Inx.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10279
Party NameWoolsey Pharmaceuticals, Inx.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10279
Party NameWoolsey Pharmaceuticals, Inx.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10279

Trademark Events

Event DateEvent Description
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, January 11, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 10, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 15, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, December 12, 2022USE AMENDMENT FILED
Monday, December 12, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, December 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 5, 2022SOU EXTENSION 2 GRANTED
Monday, December 5, 2022SOU EXTENSION 2 FILED
Monday, December 5, 2022TEAS EXTENSION RECEIVED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 1 FILED
Tuesday, October 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, September 10, 2022NOTICE OF REVIVAL - E-MAILED
Friday, September 9, 2022EXTENSION RECEIVED WITH TEAS PETITION
Friday, September 9, 2022PETITION TO REVIVE-GRANTED
Friday, September 9, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, July 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 10, 2021ASSIGNED TO EXAMINER
Tuesday, May 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 19, 2021NEW APPLICATION ENTERED

Related Keywords

bravyl system pharmaceutical nervous acting central preparations agents affecting peripheral